ResMed Inc. (RMD) Guidance & Earnings Results
On 2026-08-06 ResMed Inc. raised guidance: ">$1.85B capital return guided for…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
RMDResMed Inc.Follow RMD — free
—
Price chart with a free account
- Market cap
- 36.5B
- P/E TTM
- 24.2
- Dividend yield
- 0.9%
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 6 Aug 26 | Raised | >$1.85B capital return guided for FY2027 · full year |
| 7 Jul 26 | Reaffirmed | Reiterates FY2026 non-GAAP gross margin, SG&A%, R&D%, and tax rate; RCS segment expected to accelerate to high single-digit revenue growth in FY2027. · full year |
| 29 Jan 26 | Raised | Revenue +11% YoY, non-GAAP EPS +16% |
ResMed Inc. — questions
- What guidance did ResMed Inc. give?
- On 2026-08-06: ">$1.85B capital return guided for FY2027"
- When does ResMed Inc. report earnings?
- ResMed Inc.'s next earnings report is expected on 2026-10-29.
Every figure on this page comes from ResMed Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.